Glutaminase 1 (GLS1) is highly expressed in HCC, and GLS1 overexpression has been found to decrease ROS levels, reduce the inhibitory effect of ROS on the pathway and enhance CSC stemness (117). Here, GLS is linked to hepatocellular carcinoma.